Watchlist Price Alert

Processa Pharmaceuticals ... (PCSA)

NASDAQ: PCSA · Real-Time Price · USD

0.24

-0.00 (-1.40%)

At close: May 23, 2025, 2:28 PM

-1.40% (1D)

Bid	0.24
Market Cap	2.88M
Revenue (ttm)	n/a
Net Income (ttm)	-11.96M
EPS (ttm)	-3.06
PE Ratio (ttm)	-0.08
Forward PE	-0.28
Analyst	Buy

Ask	0.24
Volume	8,478,816
Avg. Volume (20D)	2,566,490
Open	0.25
Previous Close	0.24
Day's Range	0.23 - 0.32
52-Week Range	0.15 - 3.10
Beta	1.35

About PCSA

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol PCSA

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for PCSA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

3 months ago

-3.7%

Processa Pharmaceuticals shares are trading lower ... Unlock content with Pro Subscription

7 months ago

+0%

Processa Pharmaceuticals shares are trading higher after the company announced the dosing of its first patient for the Phase 2 trial of NGC-Cap.

News

9 months ago · investorplace.com

Why Is Processa Pharmaceuticals (PCSA) Stock Up 29% Today?

Processa Pharmaceuticals (NASDAQ: PCSA ) stock is rising higher on Tuesday after the company posted an update from the Food and Drug Administration (FDA). The FDA has cleared Processa Pharmaceuticals ...

1 year ago · investorplace.com

Why Is Processa Therapeutics (PCSA) Stock Up 90% Today?

Clinical-stage pharmaceutical company Processa Therapeutics (NASDAQ: PCSA ) — which specializes in the field of oncology — is skyrocketing on Thursday. PCSA stock is up about 90% as of this writing, a...

1 year ago · invezz.com

What made Processa Pharmaceuticals stock nearly triple on Thursday?

Processa Pharmaceuticals Inc (NASDAQ: PCSA) says it has completed a safety evaluation of its cancer treatment. Its shares rallied well over 150% on Thursday.

1 year ago · pennystocks.com

Best Penny Stocks Under $1? 4 To Watch This Week

What are the best penny stocks under $1? If you saw this headline, that's probably a question you have heading into the second half of the week.

2 years ago · zacks.com

Heatwurx Inc. (PCSA) Upgraded to Buy: Here's What You Should Know

Heatwurx Inc. (PCSA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

2 years ago · seekingalpha.com

Processa Pharmaceuticals, Inc. (PCSA) Q3 2022 Earnings Call Transcript

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Jim Stanker - CFO David Young - President & CEO Conference Call Particip...

2 years ago · seekingalpha.com

Processa Pharmaceuticals, Inc. (PCSA) CEO David Young on Q2 2022 Results - Earnings Call Transcript

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants James Stanker - Chief Financial Officer David Young - President and Chief...

3 years ago · seekingalpha.com

Processa Pharmaceuticals' (PCSA) CEO David Young on Q1 2022 Results - Earnings Call Transcript

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Jim Stanker – Chief Financial Officer David Young – Chief Executive Officer ...